Oppenheimer & CO Inc Black Rock Health Sciences Trust Transaction History
Oppenheimer & CO Inc
- $6.42 Billion
- Q3 2024
A detailed history of Oppenheimer & CO Inc transactions in Black Rock Health Sciences Trust stock. As of the latest transaction made, Oppenheimer & CO Inc holds 5,892 shares of BME stock, worth $230,023. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,892
Previous 5,922
0.51%
Holding current value
$230,023
Previous $241,000
2.49%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BME
# of Institutions
73Shares Held
3.22MCall Options Held
0Put Options Held
0-
Wells Fargo & Company San Francisco, CA428KShares$16.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY396KShares$15.5 Million0.0% of portfolio
-
Nova R Wealth, Inc.333KShares$13 Million7.19% of portfolio
-
1607 Capital Partners, LLC Richmond, VA265KShares$10.4 Million1.02% of portfolio
-
Invesco Ltd. Atlanta, GA205KShares$8.01 Million0.0% of portfolio
About BlackRock Health Sciences Trust
- Ticker BME
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in r...